Neurosense Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Neurosense Therapeutics (NRSN) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Neurosense Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Neurosense Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Neurosense Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $4.3k | 5.5k | 0.78 |
2023-09-30 | $6.9k | 9.7k | 0.71 |
2023-03-31 | $8.2k | 4.8k | 1.72 |
2022-12-31 | $5.0k | 4.1k | 1.22 |
2022-09-30 | $3.0k | 1.8k | 1.64 |
2022-06-30 | $45k | 13k | 3.35 |
2022-03-31 | $7.0k | 1.9k | 3.72 |
2021-12-31 | $20k | 8.0k | 2.49 |
Top funds holding Neurosense Therapeutics
View all funds holding Neurosense Therapeutics